This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Navsari, IN (2010)
- Gujarat, IN (2011)
Company Filing History:
Years Active: 2010-2011
Title: Hiren Gandhi: Innovator in Pharmaceutical Chemistry
Introduction
Hiren Gandhi is a notable inventor based in Gujarat, India, recognized for his contributions to pharmaceutical chemistry. With a focus on HMG-CoA reductase inhibitors, he has made significant strides in the field of drug development. His innovative work has led to the filing of two patents, showcasing his expertise and commitment to advancing medical science.
Latest Patents
Hiren Gandhi's latest patents include a process for preparing intermediates of HMG-CoA reductase inhibitors. This invention specifically relates to intermediates of rosuvastatin and outlines the processes for their production. His work in this area is crucial for the development of effective cholesterol-lowering medications.
Career Highlights
Hiren Gandhi is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role at Teva allows him to leverage his skills in research and development, contributing to the creation of innovative healthcare solutions. His dedication to improving patient outcomes through pharmaceutical advancements is commendable.
Collaborations
Hiren has collaborated with several professionals in his field, including Vinod Kumar Kansal and Brijnath P Chaurasia. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared projects.
Conclusion
Hiren Gandhi's contributions to pharmaceutical chemistry, particularly in the area of HMG-CoA reductase inhibitors, highlight his role as an influential inventor. His patents and work at Teva Pharmaceutical Industries Limited reflect his commitment to advancing healthcare through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
